CME Group registers rise in Q3 2023 revenues
International derivatives marketplace CME Group Inc. (NASDAQ:CME) today reported financial results for the third quarter of 2023.
The company reported revenue of $1.3 billion for the three months to end-September 2023, up from $1.2 billion in the year-ago quarter.
Operating income amounted to $820 million in the third quarter of 2023. Net income was $750 million and diluted earnings per common share were $2.06. On an adjusted basis, net income was $818 million and diluted earnings per common share were $2.25.
“CME Group delivered its ninth consecutive quarter of double-digit growth in adjusted earnings per share and a 9% increase in revenue as market participants continued turning to our markets to mitigate their business risks amid accelerating geopolitical uncertainty,” said CME Group Chairman and Chief Executive Officer Terry Duffy. “This was a particularly strong quarter, with interest rate volume increasing 6%, driven by an 18% rise in Treasury futures ADV and records in our Ultra 10-Year and Ultra T-Bond futures. We also generated significant growth across agricultural, energy and options products.”
Third-quarter 2023 average daily volume (ADV) was 22.3 million contracts. Non-U.S. ADV reached 6.5 million contracts, up 7% from third-quarter 2022, including 16% growth in interest rates and double-digit growth across agricultural, energy and metals products.